Sight Sciences Inc.
(SGHT)
undefined
undefined%
At close: undefined
3.58
0.28%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.
The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists.
It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States.
The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences Inc.
| Country | United States |
| IPO Date | Jul 15, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 214 |
| CEO | Paul Badawi |
Contact Details
Address: 4040 Campbell Avenue Menlo Park, California United States | |
| Website | https://www.sightsciences.com |
Stock Details
| Ticker Symbol | SGHT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001531177 |
| CUSIP Number | 82657M105 |
| ISIN Number | US82657M1053 |
| Employer ID | 80-0625749 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul Badawi | Co-Founder, President, Chief Executive Officer & Director |
| Alison Perry Bauerlein | Chief Financial Officer & Treasurer |
| Dr. David Badawi M.D. | Founder, Chief Technology Officer & Director |
| Jeremy B. Hayden J.D. | Chief Legal Officer |
| Brenton Taylor | Executive Vice President of Operations |
| Dr. Manohar Raheja Ph.D. | Executive Vice President of Research & Development |
| Dr. Reay H. Brown M.D. | Chief Medical Officer |
| Matthew W. Link | Chief Commercial Officer |
| Stephen B. Thau J.D. | Secretary |
| Steve R. Tamayo Jr. | Vice President and Chief Ethics & Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 11, 2024 | 8-K | Current Report |
| Dec 09, 2024 | 4 | Filing |
| Dec 05, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 18, 2024 | 4 | Filing |
| Nov 18, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 07, 2024 | 10-Q | Quarterly Report |